Publications

PEER-REVIEWED MANUSCRIPTS

  1. Bolanos CA, Glatt SJ, & Jackson D (1998) Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis. Brain Research: Developmental Brain Research, 111(1), 25-33.
  2. Bolanos CA, Trksak GH, Glatt SJ, & Jackson D (2000) Prenatal cocaine exposure increases serotonergic inhibition of electrically evoked acetylcholine release from rat striatal slices at adulthood. Synapse, 36(1), 1-11.
  3. Glatt SJ, Bolanos CA, Trksak GH, Crowder-Dupont C, & Jackson D (2000) Prenatal cocaine exposure alters behavioral and neurochemical sensitization to amphetamine in adult rats. Neuropharmacology, 39(4), 599-610.
  4. Glatt SJ, Bolanos CA, Trksak, GH, & Jackson D (2000) Effects of prenatal cocaine exposure on dopamine system development: a meta-analysis. Neurotoxicology and Teratology, 22(5), 617-629.
  5. Connor DF, Glatt SJ, Lopez ID, Jackson D, & Melloni RH Jr. (2002) Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 41(3), 253-261.
  6. Faraone SV, Brown CH, Glatt SJ, & Tsuang MT (2002) Preventing schizophrenia and psychotic behaviour: definitions and methodological issues. Canadian Journal of Psychiatry, 47(6), 527-537.
  7. Glatt SJ, Faraone SV, & Tsuang MT (2003) Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. American Journal of Psychiatry, 160(3), 469-476.
  8. Qian Q, Wang Y, Zhou R, Li J, Wang B, Glatt S, & Faraone SV (2003) Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. American Journal of Medical Genetics B Neuropsychiatric Genetics, 118B(1), 103-109.
  9. Faraone SV, Glatt SJ, & Tsuang MT (2003) The genetics of pediatric-onset bipolar disorder. Biological Psychiatry, 53(11), 970-977.
  10. Glatt SJ, Faraone SV, & Tsuang MT (2003) CAG-repeat length in exon 1 of KCNN3 does not influence risk for schizophrenia or bipolar disorder: a meta-analysis of association studies. American Journal of Medical Genetics B Neuropsychiatric Genetics, 121B(1), 14-20.
  11. Glatt SJ, Faraone SV, & Tsuang MT (2003) Schizophrenia is not associated with DRD4 48-base-pair-repeat length or individual alleles: results of a meta-analysis. Biological Psychiatry, 54(6), 629-635.
  12. Glatt SJ, Faraone SV, & Tsuang MT (2003) Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Molecular Psychiatry, 8(11), 911-915.
  13. Abdolmaleky HM, Faraone SV, Glatt SJ, & Tsuang MT (2004) Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophrenia Research, 67(1), 53-62.
  14. Faraone SV, Glatt SJ, Su J, & Tsuang MT (2004) Three potential susceptibility loci shown by a genome-wide scan for regions influencing the age at onset of mania. American Journal of Psychiatry, 161(4), 625-630.
  15. Abdolmaleky HM, Smith CL, Faraone SV, Shafa R, Stone W, Glatt SJ, & Tsuang MT (2004) Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation. American Journal of Medical Genetics B Neuropsychiatric Genetics, 127B(1), 51-59.
  16. Glatt SJ, Trksak GH, Cohen OS, Simeone BP, & Jackson D (2004) Prenatal cocaine exposure decreases nigrostriatal dopamine release in vitro: effects of age and sex. Synapse, 53(2), 74-89.
  17. Glatt SJ, Faraone SV, & Tsuang MT (2004) DRD2 -141C insertion/deletion polymorphism is not associated with schizophrenia: results of a meta-analysis. American Journal of Medical Genetics B Neuropsychiatric Genetics, 128B(1), 21-23.
  18. Bulayeva KB, Leal SM, Pavlova TA, Kurbanov RM, Glatt SJ, Bulayev OA, & Tsuang MT (2005) Mapping genes of complex psychiatric diseases in Daghestan genetic isolates. American Journal of Medical Genetics B Neuropsychiatric Genetics, 132B(1), 76-84.
  19. Gamma, F., Faraone SV, Glatt SJ, Yeh YC, & Tsuang MT (2005) Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene. Schizophrenia Research, 73(1), 55-58.
  20. Lasky-Su JA, Faraone SV, Glatt SJ, & Tsuang MT (2005) Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. American Journal of Medical Genetics B Neuropsychiatric Genetics, 133B(1), 110-115.
  21. Tsuang MT, Nossova N, Yager T, Tsuang MM, Guo SC, Shyu KG, Glatt SJ, & Liew CC (2005) Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. American Journal of Medical Genetics B Neuropsychiatric Genetics, 133B(1), 1-5.
  22. Glatt SJ, Wang RS, Yeh YC, Tsuang MT, & Faraone SV (2005) Five NOTCH4 polymorphisms show weak evidence for association with schizophrenia: evidence from meta-analyses. Schizophrenia Research, 73(2-3), 281-290.
  23. Abdolmaleky HM, Cheng KH, Russo A, Smith CL, Faraone SV, Wilcox M, Shafa R, Glatt SJ, Nguyen G, Ponte JF, Thiagalingam S, & Tsuang MT (2005) Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. American Journal of Medical Genetics B Neuropsychiatric Genetics, 134B(1), 60-66.
  24. Faraone SV, Biederman J, Spencer T, Michelson D, Adler L, Reimherr F, & Glatt SJ (2005) Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis. Behavioral and Brain Functions, 1, 16.
  25. Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sasik R, Khanlou N, Han M, Liew CC, & Tsuang MT (2005) Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America, 102(43), 15533-15538.
  26. Glatt SJ, & Jonsson EG (2006) The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses. American Journal of Medical Genetics B Neuropsychiatric Genetics, 141B(2), 149-154.
  27. Faraone SV, Lasky-Su J, Glatt SJ, Van Eerdewegh P, & Tsuang MT (2006) Early onset bipolar disorder: possible linkage to chromosome 9q34. Bipolar Disorders, 8(2), 144-151.
  28. Spencer TJ, Faraone SV, Michelson D, Adler LA, Reimherr FW, Glatt SJ, & Biederman J (2006) Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity. Journal of Clinical Psychiatry, 67(3), 415-420.
  29. Beseler C, Jacobson KC, Kremen WS, Lyons MJ, Glatt SJ, Faraone SV, Gillespie NA, & Tsuang MT (2006) Is there heterogeneity among syndromes of substance use disorder for illicit drugs? Addictive Behaviors, 31(6), 929-947.
  30. Seidman LJ, Giuliano AJ, Smith CW, Stone WS, Glatt SJ, Meyer E, Faraone SV, Tsuang MT, & Cornblatt B (2006) Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies. Schizophrenia Bulletin, 32(3), 507-524.
  31. Luczak SE, Glatt SJ, & Wall TL (2006) Meta-analyses of ALDH2 and ADH1B with alcohol dependence in Asians. Psychological Bulletin, 132(4), 607-621.
  32. Glatt SJ, Su JA, Zhu SC, Zhang R, Zhang B, Li J, Yuan X, Lyons MJ, Faraone SV, & Tsuang MT (2006) Genome-wide linkage analysis of heroin dependence in Han Chinese: results from wave one of a multi-stage study. American Journal of Medical Genetics B Neuropsychiatric Genetics, 141B(6), 648-652.
  33. Ozdemir V, Williams-Jones B, Glatt SJ, Tsuang MT, Lohr JB, & Reist C (2006) Shifting emphasis from pharmacogenomics to theragnostics. Nature Biotechnology, 24(8), 942-946.
  34. Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, Gao F, Smith CL, Shafa R, Aeali B, Carnevale J, Pan H, Papageorgis P, Ponte JF, Sivaraman V, Tsuang MT, & Thiagalingam S (2006) Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Human Molecular Genetics, 15(21), 3132-3145.
  35. Glatt SJ, Stone WS, Faraone SV, Seidman LJ, & Tsuang MT (2006) Psychopathology, personality traits and social development of young first-degree relatives of patients with schizophrenia. British Journal of Psychiatry, 189, 337-345.
  36. Kanazawa T, Glatt SJ, Tsutsumi A, Kikuyama H, Koh J, Yoneda H, & Tsuang MT (2007) Schizophrenia is not associated with the functional candidate gene ERBB3: results from a case-control study. American Journal of Medical Genetics B Neuropsychiatric Genetics, 144B(1), 113-116.
  37. Qian Q, Wang Y, Li J, Yang L, Wang B, Zhou R, Glatt SJ, & Faraone SV (2007) Evaluation of potential gene-gene interactions for attention deficit hyperactivity disorder in the Han Chinese population. American Journal of Medical Genetics B Neuropsychiatric Genetics, 144B(2), 200-206.
  38. Bulayeva KB, Glatt SJ, Bulayev OA, Pavlova TA, & Tsuang MT (2007) Genome-wide linkage scan of schizophrenia: a cross-isolate study. Genomics, 89(2), 167-177.
  39. Glatt SJ, Chayavichitsilp P, Depp C, Schork NJ, & Jeste DV (2007) Successful aging: from phenotype to genotype. Biological Psychiatry, 62(4), 282-293.
  40. Depp CA, Glatt SJ, & Jeste DV (2007) Recent advances in research on successful or healthy aging. Current Psychiatry Reports, 9(1), 7-13.
  41. Domschke K, Deckert J, O'Donovan MC, & Glatt SJ (2007) Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. American Journal of Medical Genetics B Neuropsychiatric Genetics, 144B(5), 667-673.
  42. Glatt SJ, Bousman C, Wang RS, Murthy KK, Rana BK, Lasky-Su JA, Zhu SC, Zhang R, Li J, Zhang B, Lyons MJ, Faraone SV, & Tsuang MT (2007) Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. Drug and Alcohol Dependence, 90(2-3), 159-165.
  43. Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, & Tsuang MT (2007) Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatric Genetics, 17(3), 165-170.
  44. Ozdemir V, Williams-Jones B, Graham JE, Preskorn SH, Gripeos D, Glatt SJ, Friis RH, Reist C, Szabo S, Lohr JB, & Someya T (2007) Asymmetry in scientific method and limits to cross-disciplinary dialogue: toward a shared language and science policy in pharmacogenomics and human disease genetics. Journal of Investigative Medicine, 55(3), 130-141.
  45. Kia-Keating BM, Glatt SJ, & Tsuang MT (2007) Meta-analyses suggest association between COMT, but not HTR1B, alleles, and suicidal behavior. American Journal of Medical Genetics B Neuropsychiatric Genetics, 144B(8), 1048-1053.
  46. Trksak GH, Glatt SJ, Mortazavi F, & Jackson D (2007) A meta-analysis of animal studies on disruption of spatial navigation by prenatal cocaine exposure. Neurotoxicology and Teratology, 29(5), 570-577.
  47. Adler LA, Faraone SV, Spencer TJ, Michelson D, Reimherr FW, Glatt SJ, Marchant BK, & Biederman J (2008) The reliability and validity of self- and investigator ratings of ADHD in adults. Journal of Attention Disorders, 11(6), 711-719.
  48. Kanazawa T, Chana G, Glatt SJ, Mizuno H, Masliah E, Yoneda H, Tsuang MT, & Everall IP (2008) The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: replication in schizophrenia and extension to bipolar disorder with psychosis. American Journal of Medical Genetics B Neuropsychiatric Genetics, 147B(6), 686-689.
  49. Le-Niculescu H, McFarland MJ, Ogden CA, Balaraman Y, Patel S, Tan J, Rodd ZA, Paulus M, Geyer MA, Edenberg HJ, Glatt SJ, Faraone SV, Nurnberger JI, Kuczenski R, Tsuang MT, & Niculescu AB (2008) Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. American Journal of Medical Genetics B Neuropsychiatric Genetics, 147B(2), 134-166.
  50. Glatt SJ, Lasky-Su, JA, Zhu SC, Zhang R, Zhang B, Li J, Yuan X, Lyons MJ, Faraone SV, & Tsuang MT (2008) Genome-wide linkage analysis of heroin dependence in Han Chinese: results from Wave Two of a multi-stage study. Drug and Alcohol Dependence, 98(1-2), 30-34.
  51. Jacobson KC, Beseler CL, Lasky-Su J, Faraone SV, Glatt SJ, Kremen WS, Lyons MJ, & Tsuang MT (2008) Ordered subsets linkage analysis of antisocial behavior in substance use disorder among participants in the Collaborative Study on the Genetics of Alcoholism. American Journal of Medical Genetics B Neuropsychiatric Genetics, 147B(7), 1258-1269.
  52. Chen C, Glatt SJ, & Tsuang MT (2008) The tryptophan hydroxylase gene influences risk for bipolar disorder but not major depressive disorder: results of meta-analyses. Bipolar Disorders, 10(7), 816-821.
  53. Glatt SJ, Faraone SV, Lasky-Su JA, Kanazawa T, Hwu HG, & Tsuang MT (2009) Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan. Molecular Psychiatry, 14(9), 885-893.
  54. Faraone SV, Glatt SJ, Bukstein OG, Lopez FA, Arnold LE, & Findling RL (2009) Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD. Journal of Attention Disorders, 12(4), 308-315.
  55. Bousman CA, Glatt SJ, Everall IP, & Tsuang MT (2009) Genetic association studies of methamphetamine use disorders: A systematic review and synthesis. American Journal of Medical Genetics B Neuropsychiatric Genetics, 150B(8), 1025-1049.
  56. Glatt SJ, Chandler SD, Bousman CA, Chana G, Lucero GR, Tatro E, May T, Lohr JB, Kremen WS, Everall IP, & Tsuang MT (2009) Alternatively spliced genes as biomarkers for schizophrenia, bipolar disorder and psychosis: A blood-based spliceome-profiling exploratory study. Current Pharmacogenomics and Personalized Medicine, 7(3), 164-188.
  57. Kanazawa T, Glatt SJ, Faraone SV, Hwu HG, Yoneda H, & Tsuang MT (2009) Family-based association study of SELENBP1 in schizophrenia. Schizophrenia Research, 113(2-3), 268-272.
  58. Pierce K, Glatt SJ, Liptak GS, & McIntyre LL (2009) The power and promise of identifying autism early: insights from the search for clinical and biological markers. Annals of Clinical Psychiatry, 21(3), 132-147.
  59. McGrath CL, Glatt SJ, Sklar P, Le-Niculescu H, Kuczenski R, Doyle AE, Biederman J, Mick E, Faraone SV, Niculescu AB, & Tsuang MT (2009) Evidence for genetic association of RORB with bipolar disorder. BMC Psychiatry, 9, 70.
  60. Ramanathan S, & Glatt SJ (2009) Serotonergic system genes in psychosis of Alzheimer dementia: meta-analysis. American Journal of Geriatric Psychiatry, 17(10), 839-846.
  61. Adler LA, Spencer TJ, Biederman J, Kollins C, Weisler R, Goodman D, & Glatt SJ (2009) The internal consistency and validity of the Attention-Deficit/Hyperactivity Disorder Rating Scale (ADHD-RS) with adult ADHD prompts as assessed during a clinical treatment trial. Journal of ADHD and Related Disorders, 1, 14-24.
  62. Bousman CA, Chana G, Glatt SJ, Chandler SD, Lucero GR, Tatro E, May T, Lohr JB, Kremen WS, Tsuang MT, & Everall IP (2010) Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples. American Journal of Medical Genetics B Neuropsychiatric Genetics, 153B(2), 494-502.
  63. Faraone SV, Spencer TJ, Kollins SH, & Glatt SJ (2010) Effects of lisdexamfetamine dimesylate treatment for ADHD on growth. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 24-32.
  64. Bousman CA, Cherner M, Glatt SJ, Atkinson H, Grant I, Tsuang MT, & Everall IP (2010) Impact of COMT Val158Met on executive functioning in the context of HIV and methamphetamine. Neurobehavioral HIV Medicine, 2, 1-11.
  65. Faraone SV, & Glatt SJ (2010) Effects of extended-release guanfacine on ADHD symptoms and sedation-related adverse events in children with ADHD. Journal of Attention Disorders, 13(5), 532-538.
  66. Faraone SV, Spencer TJ, Kollins SH, & Glatt SJ (2010) Moderators of dose-response effects of lisdexamfetamine dimesylate treatment in children with ADHD. Journal of ADHD and Related Disorders, 1, 16-24.
  67. Faraone SV, Spencer TJ, Kollins SH, Glatt SJ, & Goodman D (2010) Dose-response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: An exploratory study. Journal of Attention Disorders.
  68. Faraone SV, & Glatt SJ (2010) A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. Journal of Clinical Psychiatry, 71(6), 754-763.
  69. Bousman CA, Glatt SJ, Cherner M, Atkinson JH, Grant I, Tsuang MT, Everall IP, & the HNRC Group (2010) Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Research, 178, 295-298.
  70. Bousman CA, Chana G, Glatt SJ, Chandler SD, May T, Lohr J, Kremen WS, Tsuang MT, & Everall IP (2010) Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood. American Journal of Medical Genetics B Neuropsychiatric Genetics, 153B(7), 1336-1341.
  71. Hokyo A, Kanazawa T, Uenishi H, Tsutsumi A, Kawashige S, Kikuyama H, Glatt SJ, Koh J, Nishimoto Y, Matsumura H, Motomura N, & Yoneda H (2010) Habituation in prepulse inhibition is affected by a polymorphism on the NMDA receptor 2B subunit gene (GRIN2B) Psychiatric Genetics, 20(5), 191-198.
  72. Waxmonsky J, Waschbusch DA, Glatt SJ, & Faraone SV (in press) Prediction of placebo response in clinical trials of lisdexamfetamine dimesylate for the treatment of ADHD. Journal of Clinical Psychiatry.
  73. Bousman CA, Chana G, Glatt SJ, Chandler SD, May T, Lohr J, Everall IP, Kremen WS, & Tsuang MT (2010) Exploration of a genomic expression and pathway analysis approach to neurocognitive performance: Preliminary findings. Neurobehavioral HIV Medicine, 2, 23-32.
  74. Glatt SJ, Cohen OS, Faraone SV, & Tsuang MT (2011) Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders. American Journal of Medical Genetics B Neuropsychiatric Genetics, 156(4), 382-392.
  75. Liu L, Guan LL, Chen Y, Ji N, Li HM, Li ZH, Qian QJ, Yang L, Glatt SJ, Faraone SV, &Wang YF. (2011) Association analyses of MAOA in Chinese Han subjects with attention-deficit/hyperactivity disorder: Family-based association test, case-control study, and quantitative traits of impulsivity. American Journal of Medical Genetics B Neuropsychiatric Genetics, 156(6):737-748.
  76. Adler LA, Shaw DM, Faraone SV, Spencer TJ, Newcorn JH, Sitt DJ, Glatt SJ, Morrill MS, & Davidow J (2011) Reliability and validity of the Time-Sensitive ADHD Symptom Scale (TASS) in adults. Comprehensive Psychiatry, 52(6):769-73.
  77. Bulayeva KB, Lencz T, Glatt S, Takumi T, Gurgenova FR, & Bulayev OA (in press) Genome-wide linkage scan of major depressive disorder in two Dagestan genetic isolates. Central European Journal of Medicine.
  78. Glatt SJ, Stone WS, Nossova N, Liew C-C, Seidman LJ, & Tsuang MT (2011) Similarities and differences in peripheral blood gene expression signatures of individuals with schizophrenia and their first-degree biological relatives. American Journal of Medical Genetics B Neuropsychiatric Genetics, 156(8), 869-887.
  79. Tsutsumi A, Glatt SJ, Kanazawa T, Kawashige S, Uenishi H, Hokyo A, Kaneko T, Moritani K, Kikuyama H, Matsumura H, Koh J, & Yoneda H (2011) The genetic validation of heterogeneity in schizophrenia. Behavioral and Brain Functions, 7:43.
  80. Woelk CH, Singhania A, Perez-Santiago J, Glatt SJ, & Tsuang MT (2011) The utility of gene expression in blood cells for diagnosing neuropsychiatric disorders. International Review of Neurobiology, 101:41-63.

BOOKS

  1. Tsuang MT, Faraone SV, & Glatt SJ (2011) Schizophrenia: The Facts. 130 pp. Oxford: Oxford University Press.

CHAPTERS

  1. Faraone SV, Glatt SJ, & Taylor L (2004) The Genetic Basis of Schizophrenia. In: Stone WS, Faraone SV, & Tsuang MT (Editors) Early Clinical Intervention and Prevention of Schizophrenia. Totowa, NJ: Humana Press; pp. 3-23.
  2. Stone WS, Glatt SJ, & Faraone SV (2004) The Biology of Schizotaxia. In: Stone WS, Faraone SV, & Tsuang MT (Editors) Early Clinical Intervention and Prevention of Schizophrenia. Totowa, NJ: Humana Press; pp. 339-355.
  3. Tsuang MT, Stone WS, Glatt SJ, & Faraone SV (2005) Schizophrenia Spectrum: Pathology and Treatment. In: Sadock BJ, & Sadock VA (Editors) Kaplan and Sadock's Comprehensive Textbook of Psychiatry, Eighth Edition. Philadelphia, PA: Lippincott, Williams & Wilkins; pp. 1502-1512.
  4. Tsuang MT, Glatt SJ, & Faraone SV (2006) The Complex Genetics of Psychiatric Disorders. In: Runge MS, & Patterson WC (Editors) Principles of Molecular Medicine, Second Edition. Totowa, NJ: Humana Press; pp. 1186-1192.
  5. Glatt SJ, Faraone SV, & Tsuang MT (2007) Genetic Risk Factors for Mental Disorders: General Principles and State of the Science. In: Tsuang MT, Stone WS, & Lyons MJ (Editors) Recognition and Prevention of Major Mental and Substance Abuse Disorders. Washington, DC: American Psychiatric Publishing, Inc.; pp. 3-20.
  6. Glatt SJ, Faraone SV, & Tsuang MT (2008) Psychiatric genetics: A Primer. In: Smoller JW, Tsuang MT, & Rosen-Sheidley B (Editors) Psychiatric Genetics: Applications in Clinical Practice. Arlington, VA: American Psychiatric Publishing, Inc.; pp. 3-32.
  7. Glatt SJ (2008) Genetics. In: Mueser KT, & Jeste DV (Editors) Clinical Handbook of Schizophrenia. New York, NY: Guilford Press; pp. 55-64.
  8. Glatt SJ, Faraone SV, & Tsuang MT (2008) Mental Health Etiology: Biological and Genetic Determinants. In: Heggenhougen HK, & Quah SR (Editors) International Encyclopedia of Public Health. San Diego, CA: Academic Press; pp. 343-349.
  9. Chana G, Glatt SJ, Everall IP, & Tsuang MT (2009) Blood and Brain Gene Expression in Major Psychiatric Disorders: A Search for Biomarkers. In: Turck CW (Editor) Biomarkers for Psychiatric Disorders. New York, NY: Springer US; pp. 1-22.
  10. Chana G, Kwok J, Glatt SJ, Everall IP, & Tsuang MT (2009) Gene Expression Changes and Potential Impact of Endophenotypes in Major Psychiatric Disorders. In: Ritsner MS (Editor) Neuropsychiatric Biomarkers, Endophenotypes, and Genes: Promises, Advances, and Challenges. New York, NY: Springer US; 77-93.
  11. Glatt SJ & Profenno, L. A. (2009) Genetics of Late-Life Neurodegenerative Disorders. In: Sadock BJ, & Sadock VA (Editors) Kaplan and Sadock's Comprehensive Textbook of Psychiatry, Ninth Edition. Philadelphia, PA: Lippincott, Williams & Wilkins; pp. 4003-4009.
  12. Glatt SJ, Faraone SV, & Tsuang MT (2010) Mental Health Etiology: Biological and Genetic Determinants. In: Patel V, Woodward A, Feigin VL, Heggenhougen HK, & Quah S (Editors) Mental and Neurological Public Health: A Global Perspective. Chennai, India: Elsevier Publishing Services Chennai; pp. 107-113.
  13. Bousman CA, Chana G, Tatro ET, Glatt SJ, Tsuang MT, & Everall IP (2010) Biomarker Discovery in Major Psychiatric Disorders: Approaches, Limitations, and Future Directions. In: Urbano KV (Editor) Advances in Genetic Research. Hauppauge, NY: Nova Science Publishers, Inc.
  14. Faraone SV, Glatt SJ, &Tsuang MT (2011) Genetic Epidemiology. In: Tsuang MT, Tohen M, & Jones P (Editors) Textbook in Psychiatric Epidemiology, Third Edition. London, UK: John Wiley & Sons, Ltd.; pp. 31-55.
  15. Mostafavi-Abdolmaleky H, Glatt SJ, & Tsuang MT (2011) Epigenetics in Psychiatry. In: Roach HI, & Bronner F (Editors) Epigenetic Aspects of Chronic Diseases. Springer; pp. 163-173.
  16. Bousman CA, Glatt SJ, Everall IP, & Tsuang MT (2011). Methamphetamine associated psychosis: A model for biomarker discovery in schizophrenia. In: M. Ritsner (Editor). Textbook of Schizophrenia Spectrum Disorders. New York, NY: Springer; pp. 327-343.